Heart rhythm ablation outcomes in minority patients
Part of Heart & circulation clinical trials.
This registry tracks outcomes for racial and ethnic minority patients undergoing a specific type of heart rhythm treatment (ablation) for atrial fibrillation. The goal is to understand how well this treatment works across different populations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as a racial or ethnic minority
- You have atrial fibrillation (AFib) that your doctor recommends treating with ablation
- Your AFib has lasted less than 1 year, or is paroxysmal (comes and goes)
- This would be your first ablation procedure, or your first one was also in this registry
- You are age 18 or older
- You can attend baseline and follow-up appointments throughout the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial compares a newer type of ablation (pulsed field) with the standard radiofrequency ablation for people with persistent atrial fibrillation that hasn't been treated with ablation before. The goal is to see which method works better and has fewer risks.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.